BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25384689)

  • 21. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
    Rimek D; Redetzke K; Kappe R
    Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida norvegensis fungemia in a liver transplant recipient.
    Sanclemente G; Marco F; Cervera C; Hoyo I; Colmenero J; Pitart C; Almela M; Navasa M; Moreno A
    Rev Iberoam Micol; 2015; 32(2):115-7. PubMed ID: 24794213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
    Oxman DA; Chow JK; Frendl G; Hadley S; Hershkovitz S; Ireland P; McDermott LA; Tsai K; Marty FM; Kontoyiannis DP; Golan Y
    J Antimicrob Chemother; 2010 Jul; 65(7):1460-5. PubMed ID: 20430790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel.
    Ben-Ami R; Rahav G; Elinav H; Kassis I; Shalit I; Gottesman T; Megged O; Weinberger M; Ciobotaro P; Shitrit P; Weber G; Paz A; Miron D; Oren I; Bishara J; Block C; Keller N; Kontoyiannis DP; Giladi M;
    Clin Microbiol Infect; 2013 Aug; 19(8):752-6. PubMed ID: 23005038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
    Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
    Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
    Durán MT; Velasco D; Canle D; Moure R; Villanueva R
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
    Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
    Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakthrough candidaemia in the era of broad-spectrum antifungal therapies.
    Cuervo G; Garcia-Vidal C; Nucci M; Puchades F; Fernández-Ruiz M; Obed M; Manzur A; Gudiol C; Pemán J; Aguado JM; Ayats J; Carratalà J
    Clin Microbiol Infect; 2016 Feb; 22(2):181-188. PubMed ID: 26460064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal invasive candidiasis in Tunisian hospital: incidence, risk factors, distribution of species and antifungal susceptibility.
    Ben Abdeljelil J; Saghrouni F; Nouri S; Geith S; Khammari I; Fathallah A; Sboui H; Ben Saïd M
    Mycoses; 2012 Nov; 55(6):493-500. PubMed ID: 22448706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing epidemiology of candidaemia in Australia.
    Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S;
    J Antimicrob Chemother; 2017 Apr; 72(4):1103-1108. PubMed ID: 28364558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010.
    Chen CY; Huang SY; Tsay W; Yao M; Tang JL; Ko BS; Chou WC; Tien HF; Hsueh PR
    Int J Antimicrob Agents; 2012 Dec; 40(6):533-8. PubMed ID: 23006521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
    Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
    Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006.
    Chen PL; Lo HJ; Wu CJ; Lee HC; Chang CM; Lee NY; Wang AH; Lin WL; Ko NY; Lee CC; Ko WC
    Mycoses; 2011 Jul; 54(4):e17-23. PubMed ID: 20028463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation of Candida species isolated from blood cultures during 17 years in a university hospital.
    Kazak E; Akın H; Ener B; Sığırlı D; Özkan Ö; Gürcüoğlu E; Yılmaz E; Çelebi S; Akçağlar S; Akalın H
    Mycoses; 2014 Oct; 57(10):623-9. PubMed ID: 24934185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medellín, Colombia 2010-2011.
    Maldonado NA; Cano LE; De Bedout C; Arbeláez CA; Roncancio G; Tabares AM; Robledo CG; Robledo J;
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):280-6. PubMed ID: 24666706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
    Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
    Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.
    Pu S; Niu S; Zhang C; Xu X; Qin M; Huang S; Zhang L
    J Microbiol Immunol Infect; 2017 Feb; 50(1):97-103. PubMed ID: 25769664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.